1. Timing and Timeliness in Medical Care Evaluation

   • Bernard S. Bloom
   • A. Mark Fendrick

   Current Opinion 17 September 2012 Pages: 183 - 187

2. The Pharmacoeconomics of ACE Inhibitors in Chronic Heart Failure

   • John McMurray
   • Andrew Davie

   Leading Article 17 September 2012 Pages: 188 - 197

3. Outcomes Assessment of Drug Treatment in Multiple Sclerosis Clinical Trials

   • Margaret Malone
   • Ben Lomaestro

   Review Article 17 September 2012 Pages: 198 - 210

4. Cost-Effective Policies for Cervical Cancer Screening

   • Marianne C. Fahs
   • Stacey B. Plichta
   • Jeanne S. Mandelblatt

   Review Article 17 September 2012 Pages: 211 - 230

5. Direct Costs of Osteoporosis For New Zealand Women

   • Annika Lane

   Original Research Article 17 September 2012 Pages: 231 - 245

6. Drug Use in Relation to Clinical Activities as an Instrument for Prospective Drug Budgeting

   • Marie-Christine Closon
   • Ralph Crott
   • Danièle Even-Adin

   Original Research Article 17 September 2012 Pages: 246 - 263

7. A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials

   • Josephine Mauskopf
   • Kevin Schulman
   • Henry Glick

   Special Article 17 September 2012 Pages: 264 - 277